Miami Gardens

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease2 trials
• Schizophrenia2 trials
• Bipolar disorder1 trial
• Psoriasis1 trial
• Psoriatic arthritis1 trial

Phase

• Phase 22 trials
• Phase 32 trials

Status

• Active, not recruiting1 trial
• Completed1 trial
• Enrolling by invitation1 trial
• Recruiting1 trial

Lead sponsor

• MapLight Therapeutics2 trials
• Intra-Cellular Therapies, Inc.1 trial
• MoonLake Immunotherapeutics AG1 trial

Running trials

• Enrolling by invitation

  An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis

  NCT07459660· Phase 2· MapLight Therapeutics· Source

• Recruiting

  A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

  NCT06887192· Phase 2· MapLight Therapeutics· Source

• Active, not recruiting

  Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response

  NCT06641089· Phase 3· MoonLake Immunotherapeutics AG· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease2 recruiting
• Schizophrenia2 recruiting

Closed trials

• Completed

  Study of Lumateperone in the Acute Treatment of Patients With Bipolar Mania

  NCT06462586· Phase 3· Intra-Cellular Therapies, Inc.· Source